Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ray Borrow

Showing results (321-330 of 403) with videos related to

Pageof 41
Sort By:
Plos Neglected Tropical Diseases|December 3, 2008
Immunogenicity of fractional doses of tetravalent a/c/y/w135 meningococcal polysaccharide vaccine: results from a randomized non-inferiority controlled trial in UgandaPhilippe J Guerin, Lisbeth M Naess, Carole Fogg, et al.
Clinical and Vaccine Immunology : CVI|October 27, 2006
Immunogenicity and safety of three doses of a bivalent (B:4:p1.19,15 and B:4:p1.7-2,4) meningococcal outer membrane vesicle vaccine in healthy adolescentsDominique Boutriau, Jan Poolman, Ray Borrow, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 17, 2015
Antibody responses after primary immunization in infants born to women receiving a pertussis-containing vaccine during pregnancy: single arm observational study with a historical comparatorShamez N Ladhani, Nick J Andrews, Jo Southern, et al.
The Lancet. Infectious Diseases|October 31, 2015
Genomic epidemiology of age-associated meningococcal lineages in national surveillance: an observational cohort studyDorothea M C Hill, Jay Lucidarme, Stephen J Gray, et al.
Mbio|October 30, 2024
High-throughput phenotype-to-genotype testing of meningococcal carriage and disease isolates detects genetic determinants of disease-relevant phenotypic traitsRobeena Farzand, Mercy W Kimani, Evangelos Mourkas, et al.
Vaccine|February 5, 2018
Natural immunity against capsular group X N. meningitidis following an outbreak in Togo, 2007Gunnstein Norheim, Judith E Mueller, Berthe-Marie Njanpop-Lafourcade, et al.
The New England Journal of Medicine|January 24, 2020
Meningococcal B Vaccine and Meningococcal Carriage in Adolescents in AustraliaHelen S Marshall, Mark McMillan, Ann P Koehler, et al.
Human Vaccines & Immunotherapeutics|July 4, 2023
Safety and immunogenicity of quadrivalent meningococcal polysaccharide vaccine (MPV ACYW135) compared with quadrivalent meningococcal conjugate vaccine (Menactra®) in Malian childrenSamba O Sow, Milagritos D Tapia, Fadima Cheick Haidara, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 11, 2015
Human Complement Bactericidal Responses to a Group A Meningococcal Conjugate Vaccine in Africans and Comparison to Responses Measured by 2 Other Group A ImmunoassaysGregory A Price, Aimee M Hollander, Brian D Plikaytis, et al.
Vaccine|July 14, 2020
To our readers: Important noticeGregory A Poland, Nicolette van Dijk, Danny Altmann, et al.
Pageof 41

Showing results (321-330 of 403) with videos related to

Sort By:
Pageof 41
Plos Neglected Tropical Diseases|December 3, 2008
Immunogenicity of fractional doses of tetravalent a/c/y/w135 meningococcal polysaccharide vaccine: results from a randomized non-inferiority controlled trial in UgandaPhilippe J Guerin, Lisbeth M Naess, Carole Fogg, et al.
Clinical and Vaccine Immunology : CVI|October 27, 2006
Immunogenicity and safety of three doses of a bivalent (B:4:p1.19,15 and B:4:p1.7-2,4) meningococcal outer membrane vesicle vaccine in healthy adolescentsDominique Boutriau, Jan Poolman, Ray Borrow, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 17, 2015
Antibody responses after primary immunization in infants born to women receiving a pertussis-containing vaccine during pregnancy: single arm observational study with a historical comparatorShamez N Ladhani, Nick J Andrews, Jo Southern, et al.
The Lancet. Infectious Diseases|October 31, 2015
Genomic epidemiology of age-associated meningococcal lineages in national surveillance: an observational cohort studyDorothea M C Hill, Jay Lucidarme, Stephen J Gray, et al.
Mbio|October 30, 2024
High-throughput phenotype-to-genotype testing of meningococcal carriage and disease isolates detects genetic determinants of disease-relevant phenotypic traitsRobeena Farzand, Mercy W Kimani, Evangelos Mourkas, et al.
Vaccine|February 5, 2018
Natural immunity against capsular group X N. meningitidis following an outbreak in Togo, 2007Gunnstein Norheim, Judith E Mueller, Berthe-Marie Njanpop-Lafourcade, et al.
The New England Journal of Medicine|January 24, 2020
Meningococcal B Vaccine and Meningococcal Carriage in Adolescents in AustraliaHelen S Marshall, Mark McMillan, Ann P Koehler, et al.
Human Vaccines & Immunotherapeutics|July 4, 2023
Safety and immunogenicity of quadrivalent meningococcal polysaccharide vaccine (MPV ACYW135) compared with quadrivalent meningococcal conjugate vaccine (Menactra®) in Malian childrenSamba O Sow, Milagritos D Tapia, Fadima Cheick Haidara, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 11, 2015
Human Complement Bactericidal Responses to a Group A Meningococcal Conjugate Vaccine in Africans and Comparison to Responses Measured by 2 Other Group A ImmunoassaysGregory A Price, Aimee M Hollander, Brian D Plikaytis, et al.
Vaccine|July 14, 2020
To our readers: Important noticeGregory A Poland, Nicolette van Dijk, Danny Altmann, et al.
Pageof 41